Related Experiment Videos
Shewanella (Pseudomonas) putrefaciens bacteremia
A J Brink1, A van Straten, A J van Rensburg
1Department of Medical Microbiology, University of Pretoria, South Africa.
Summary
Shewanella putrefaciens bacteremia is rare but documented in 28 cases, affecting neonates, children, and adults. This study identifies distinct clinical syndromes associated with S. putrefaciens bloodstream infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Bacteriology
Background:
- Shewanella (Pseudomonas) putrefaciens is an infrequently reported human pathogen.
- Previous literature documented only 13 cases of S. putrefaciens bacteremia.
- This study expands the known cases to 28, providing a larger dataset for analysis.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of 28 cases of S. putrefaciens bacteremia.
- To identify potential clinical syndromes associated with S. putrefaciens bloodstream infections.
- To evaluate the role of S. putrefaciens as a pathogen in human sepsis.
Main Methods:
- Retrospective analysis of 28 patient cases with S. putrefaciens bacteremia.
- Review of patient demographics, clinical presentations, and outcomes.
- Analysis of co-existing conditions and polymicrobial infections.
Main Results:
- The 28 cases included 16 neonates, 9 adults, and 3 children under 1 year.
- Neonates commonly presented with respiratory distress and pneumonia.
- Adult cases were often associated with lower extremity trauma; sepsis-related deaths occurred primarily in neutropenic patients.
- Polymicrobial bacteremia was present in 18 of the 28 cases.
- Three distinct clinical syndromes were proposed: prematurity/congenital pneumonia, lower extremity ulceration, and underlying debility.
Conclusions:
- Shewanella putrefaciens can cause bloodstream infections in diverse patient populations.
- Distinct clinical presentations suggest specific syndromes associated with S. putrefaciens bacteremia.
- The frequent occurrence of polymicrobial infections complicates the definitive assessment of S. putrefaciens' pathogenic role in sepsis.